CDx CEO Daniel Yazbeck Featured Panelist at Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CDx CEO Daniel Yazbeck Featured Panelist at Marijuana Investor, Technology and Healthcare Events

LA JOLLA, Calif., April 16, 2015 (GLOBE NEWSWIRE) -- CDx, Inc. , developers of MyDx (My Diagnostic), the first handheld analyzer technology for the cannabis industry, is on a mission to help consumers trust & verify what they ingest into their bodies easily, inexpensively and in real time. The San Diego based science and technology company has developed the MyDx Analyzer , which is a game-changing portable 'electronic nose' to bring handheld testing capabilities to consumers. It leverages the latest in nanotechnology to accurately measure chemicals of interest, anywhere, anytime.

"Our vision for MyDx is to empower consumers to test the safety and potency of everything they eat, drink and inhale," says Daniel Yazbeck, CDx CEO scientist, inventor, and former business consultant to Fortune 500 companies including Pfizer Pharmaceuticals and Panasonic.

This proprietary technology, which was used by NASA, is centered on a portable chemical sensing and analyzing methodology. The company's first product suite includes the MyDx Analyzer , CannaDx Sensor , and MyDx App . Together the device analyzes chemical and molecule profiles present in a given cannabis sample.

"MyDx will be able to analyze a wide array of substances in food, water and plants using one main device, the MyDx Analyzer, with interchangeable MyDx Sensors," says Yazbeck.

Daniel Yazbeck will be a featured speaker at the following April events:

MedMJ Denver - Denver, CO

April 20 - 2:30pm-3:30pm

Topic: Technology and Software in the MMJ Space

Marijuana Investor Summit - Denver, CO

April 21 - 9:45am-10:30am

Topic: Technology & Marijuana

ArcView DC Investor Forum, Shark Panel, Alexandria, VA

May 1 – Morning Session

Topic:  Shark Panel Pitch Sessions for New Cannabis Entrepreneurs.

About Daniel Yazbeck

Daniel Yazbeck is a leading science, business and technology professional with nearly 15 years experience guiding a variety of Fortune 500 companies. He has worked with Pfizer Pharmaceuticals as a Scientist specializing in chemical R &D technologies, as well as Panasonic, spearheading their new market, business and strategic product development activities in the Consumer Electronics Healthcare field. Daniel holds a Master's Degree in Medicinal Chemistry from McGill University with a minor in Marketing, and is an inventor and author of several world patents and research publications. To learn more, please visit www.yazbeckinvestments.com .

About CDx Inc.   (Meet Mollie Molecule video )

CDx Inc., founded by Daniel Yazbeck, empowers people to live a healthier life by revealing the purity of what they eat, drink & inhale in the palm of their hands and in real time.  The company's first product, MyDx, aka "My Diagnostic." leverages the latest in nanotechnology to accurately measure chemicals of interest in nearly any solid, liquid, or gas sample, anywhere, anytime.  To learn more, please visit www.cdxlife.com .

A photo accompanying this release is available at:

http://www.globenewswire.com/newsroom/prs/?pkgid=32182

Gaynell Rogers (415) 298-1114

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ares Commercial Real Estate Gears Up for Q3 Earnings

Updated Category News Views 21

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Continue Reading
HumanView Relaunch: LEAP Group Decodes Customer Signals

Updated Category News Views 52

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading

Top 5 Most Recently Viewed Articles

Columbus McKinnon Completes Significant Notes Offering for Growth

Updated Category News Views 97

Columbus McKinnon Completes Important Notes Offering Columbus McKinnon Corporation (NASDAQ: CMCO), a prominent designer and manufacturer in the intelligent motion solutions sector, has successfully completed a notable offering of senior secured notes. This offering totaled $900 million with a set interest rate of 7.125%, maturing in 2033, aimed at supporting the company's...

Continue Reading
Navigating TransMedics Gr's Upcoming Earnings Like a Pro

Updated Category News Views 195

Rollin' into Earnings: What to Expect from TMDX Every now and then, a company catches wind in its sails, and TransMedics Gr (NASDAQ:TMDX)—well, it’s been riding a decent wave lately. With earnings about to drop on February 24, 2026, folks are buzzing, holding their breath, and looking for that golden info nugget to drop. Analysts are pinning their hopes on an earnings...

Continue Reading
Rigel Pharmaceuticals Set to Showcase Innovations at J.P. Morgan

Updated Category News Views 108

Rigel Pharmaceuticals Gears Up for J.P. Morgan Healthcare Conference Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a prominent name in biotechnology focused on hematologic disorders and cancer treatments, is poised to make a significant impact at the upcoming J.P. Morgan Healthcare Conference. The event is set to bring together industry leaders and innovators, making it an...

Continue Reading
Big Lots Introduces Festive Shopping Event Amid Holiday Cheers

Updated Category News Views 293

Exciting Updates from Big Lots This Holiday Season Big Lots is gearing up for the holiday season with some thrilling news for all shoppers. The launch of their new Holiday Shop is set to delight customers, combined with an unforgettable one-day shopping event called ‘Falloweenmas’ which offers great savings and unique decorations for this festive time of year....

Continue Reading
Amcor Welcomes Stephen Scherger as New CFO Amid Changes

Updated Category News Views 273

Amcor Announces New Leadership with Stephen R. Scherger Amcor, a global frontrunner in packaging solutions, has appointed Stephen R. Scherger as its new Executive Vice President and Chief Financial Officer, effective November 10, 2025. This decision comes as the current CFO, Michael Casamento, steps down after dedicating a decade to the company. He will continue in an...

Continue Reading